ACUT
Price:
$0.32993
Market Cap:
$0
AccuStem Sciences, Inc. operates as a life sciences company focusing on improving outcomes for patients with cancer. It develops StemPrintER technology, a multi-gene prognostic assay to predict the risk of recurrence of Endocrine receptor-positive /HER2- breast cancer; and Spare, a derivative of StemPrintER that combines StemPrintER with two clinical markers. The company is based in New York, New York.[Read more]
Industry
Biotechnology
IPO Date
2022-03-03
Stock Exchange
PNK
Ticker
ACUT
According to Accustem Sciences Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.36. This represents a change of 418.43% compared to the average of -0.46 of the last 4 quarters.
The mean historical PE Ratio of Accustem Sciences Inc. over the last ten years is -1.39. The current -2.36 PE Ratio has changed 16.86% with respect to the historical average. Over the past ten years (40 quarters), ACUT's PE Ratio was at its highest in in the December 2021 quarter at 0. The PE Ratio was at its lowest in in the June 2023 quarter at -1.03.
Average
-1.39
Median
-1.39
Minimum
-2.39
Maximum
-0.40
Discovering the peaks and valleys of Accustem Sciences Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -0.40
Minimum Annual Increase = -83.36%
Minimum Annual PE Ratio = -2.39
Year | PE Ratio | Change |
---|---|---|
2022 | -0.40 | -83.36% |
The current PE Ratio of Accustem Sciences Inc. (ACUT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-1.39
5-year avg
-1.39
10-year avg
-1.39
Accustem Sciences Inc.’s PE Ratio is greater than Tiziana Life Sciences Ltd (-5.96), greater than Avacta Group Plc (-6.19), less than Acurx Pharmaceuticals, Inc. (-0.01), less than Alpha Cognition Inc. (-2.34), less than Aadi Bioscience, Inc. (-1.01),
Company | PE Ratio | Market cap |
---|---|---|
-5.96 | $100.36M | |
-6.19 | $164.30M | |
-0.01 | $22.80M | |
-2.34 | $35.63M | |
-1.01 | $56.69M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Accustem Sciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Accustem Sciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Accustem Sciences Inc.'s PE Ratio?
How is the PE Ratio calculated for Accustem Sciences Inc. (ACUT)?
What is the highest PE Ratio for Accustem Sciences Inc. (ACUT)?
What is the 3-year average PE Ratio for Accustem Sciences Inc. (ACUT)?
What is the 5-year average PE Ratio for Accustem Sciences Inc. (ACUT)?
How does the current PE Ratio for Accustem Sciences Inc. (ACUT) compare to its historical average?